| Dr John J Kurucz, DO | |
|
One Medical Center Drive, Biddeford, ME 04005 | |
| (207) 294-5000 | |
| (207) 294-5255 |
| Full Name | Dr John J Kurucz |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | One Medical Center Drive, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548417397 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2286 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Blue Hill Memorial Hospital | Blue hill, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medicine Services Of Maine Llc | 1052657616 | 39 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 6 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 6 days ago
| Entity Name | Southern Maine Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659392819 PECOS PAC ID: 0143208348 Enrollment ID: O20040713001060 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 6 days ago
| Entity Name | Emergency Medicine Services Of Maine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578032058 PECOS PAC ID: 1052657616 Enrollment ID: O20190118000889 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John J Kurucz, DO One Medical Center Drive, Biddeford, ME 04005 Ph: (207) 294-5000 | Dr John J Kurucz, DO One Medical Center Drive, Biddeford, ME 04005 Ph: (207) 294-5000 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 6 days ago
Margaret Shannon Griffin, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 West Cole Rd Ste 104, Biddeford, ME 04005 Phone: 207-283-1602 | |
Mr. Zachary Bernard Tillett, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Gina Marie Quinn-skillings, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7100 Fax: 207-283-7850 | |
Dr. Keith Rosenberg, M.D., M.P.H. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Madeleine Marie Puissant, MD, PHD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-662-0111 | |
Christopher P Cox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7100 Fax: 207-283-7850 | |
Dr. Jessica H Stevens, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Biddeford, ME 04005 Phone: 207-294-5000 Fax: 207-282-9180 |